Altus Pharmaceuticals   Report issue

For profit Phase 2
Founded: Independence OH United States (1996)
Status: Acquired by Ajinomoto (2009)

Organization Overview

First Clinical Trial
2005
NCT00297713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

somatropin (protropin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dwarfism, Pituitary (Phase 2)

Endocrine System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1